Several studies have previously revealed the genomic landscape of MCL tumors, which includes recurrent mutations in cancer-related genes such as ATM, CCND1, TP53, NOTCH2, or RB1 [13,14,15,16]. This evidence concerns the gene TP53 and mantle cell lymphoma.